These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 21545366)
21. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature. Di Simone N; Luigi MP; Marco D; Fiorella DN; Silvia D; Clara DM; Alessandro C Ann N Y Acad Sci; 2007 Jun; 1108():505-14. PubMed ID: 17894016 [TBL] [Abstract][Full Text] [Related]
22. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta. Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105 [TBL] [Abstract][Full Text] [Related]
23. Role of NOD2 in antiphospholipid antibody-induced and bacterial MDP amplification of trophoblast inflammation. Mulla MJ; Pasternak MC; Salmon JE; Chamley LW; Abrahams VM J Autoimmun; 2019 Mar; 98():103-112. PubMed ID: 30594350 [TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia. Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948 [TBL] [Abstract][Full Text] [Related]
25. Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. Viall CA; Chen Q; Liu B; Hickey A; Snowise S; Salmon JE; Stone PR; Chamley LW J Autoimmun; 2013 Dec; 47():45-57. PubMed ID: 24035196 [TBL] [Abstract][Full Text] [Related]
26. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia. Huang QT; Wang SS; Zhang M; Huang LP; Tian JW; Yu YH; Wang ZJ; Zhong M Placenta; 2013 Oct; 34(10):949-52. PubMed ID: 23899470 [TBL] [Abstract][Full Text] [Related]
31. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Meroni PL; Gerosa M; Raschi E; Scurati S; Grossi C; Borghi MO Clin Rev Allergy Immunol; 2008 Jun; 34(3):332-7. PubMed ID: 18175073 [TBL] [Abstract][Full Text] [Related]
32. Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Athanassiades A; Lala PK Placenta; 1998 Sep; 19(7):465-73. PubMed ID: 9778119 [TBL] [Abstract][Full Text] [Related]
33. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207 [TBL] [Abstract][Full Text] [Related]
34. ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice. Ulrich V; Gelber SE; Vukelic M; Sacharidou A; Herz J; Urbanus RT; de Groot PG; Natale DR; Harihara A; Redecha P; Abrahams VM; Shaul PW; Salmon JE; Mineo C Arthritis Rheumatol; 2016 Mar; 68(3):730-739. PubMed ID: 26474194 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor. Bolnick AD; Bolnick JM; Kohan-Ghadr HR; Kilburn BA; Pasalodos OJ; Singhal PK; Dai J; Diamond MP; Armant DR; Drewlo S Hum Reprod; 2017 Jun; 32(6):1218-1229. PubMed ID: 28402449 [TBL] [Abstract][Full Text] [Related]
36. Effects of anti-β2-GPI antibodies on cytokine production in normal first-trimester trophoblast cells. Azuma H; Yamamoto T; Chishima F J Obstet Gynaecol Res; 2016 Jul; 42(7):769-75. PubMed ID: 27098191 [TBL] [Abstract][Full Text] [Related]
37. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. Mayer-Pickel K; Stern C; Eberhard K; Lang U; Obermayer-Pietsch B; Cervar-Zivkovic M J Reprod Immunol; 2018 Jun; 127():19-23. PubMed ID: 29689494 [TBL] [Abstract][Full Text] [Related]
38. The vascular endothelial growth factor family in adverse pregnancy outcomes. Andraweera PH; Dekker GA; Roberts CT Hum Reprod Update; 2012 Jul; 18(4):436-57. PubMed ID: 22495259 [TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7. Coenen CS; Hidalgo TN; Lynn T; Jones DM; Salmon JE; Chamley LW; Abrahams VM J Reprod Immunol; 2024 Aug; 164():104255. PubMed ID: 38797133 [TBL] [Abstract][Full Text] [Related]
40. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]